Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
bristol-myers squibb
deals
3
×
biotech
celgene
giovanni caforio
life sciences
national blog main
new york
new york blog main
new york top stories
acquisitions
cancer
clinical trials
drugs
ftc
health/life sciences
hypertrophic cardiomyopathy
investing
juno therapeutics
lenalidomide
mavacamten
mergers and acquisitions
multiple myeloma
myokardia
national top stories
patent
patent cliff
psoriasis
regulators
san francisco blog main
san francisco top stories
wellington management company
What
acquire
3
×
billion
bristol
myers
3
×
celgene
deal
drug
squibb
agreement
amid
bolstering
buy
buyout
cardiovascular
company
company's
concerns
confidence
delayed
disease
divest
experimental
faces
fda
ftc
heart
institutional
investor
investors
juno
largest
lineup
major
merger
myokardia
new
news
opposed
opposition
parent
Language
unset
Current search:
myers
×
deals
×
acquire
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}